Serum Albumin Binding Research Articles

Sialic Acid-Targeted Ru(II)/Ir(III)/Re(I) Complexes for Ferroptosis Induction in Triple-Negative Breast Cancer.

Ferroptosis has been recognized as an iron-based nonapoptotic-regulated cell death process. In the quest of resisting the unyielding vehemence of triple-negative breast cancer (TNBC), herein we have showcased the ferroptosis-inducing heteroleptic [LIrcRu], [LIrcIrh], and [LIrcRe] complexes, enabling them to selectively target "sialic acid", an overexpressed cancer cell-surface marker. The open-circuit potential (OCP) measurements in live cancer cells revealed the specific interaction between TNBC and the complexes, whereas control experiments with normal cells did not exhibit such interactions. GSH depletion, GPx4 inhibition, NADH/NADPH oxidation, lipid peroxidation, COX-2 activation, and Nrf2 inactivation were meticulously investigated upon treatment with these complexes to establish a strong basis for ferroptosis. Among all complexes, the complex [LIrcIrh] (IC50 = 25 ± 2.17 μM) has been well-documented as a potent ferroptosis inducer, which unveils the sturdy interaction with sialic acid possessing the highest binding constant (Kb = 0.71 × 105 M-1, ΔG = -279345.8026 kcal/mol) along with the highest serum albumin binding affinity (KHSA = 0.67 × 106 M-1) and significant DNA intercalation (Kb = 0.56 × 105 M-1, Kapp = 1.06 × 106 M-1, and C50 of intercalation is 76.56 μM), displaying the decreased current intensity in differential pulse voltammetry (DPV). Moreover, the complex [LIrcIrh] exhibited mitochondrial dysfunction and membrane damage (diminished MMP, ΔΨm) through the production of copious reactive oxygen species (ROS) in MDA-MB-231 cells upon considerable accumulation in mitochondria (Pearson's coefficient = 0.842). The analysis of the field emission scanning electron microscopy (FE-SEM) image has marked the vivid membrane damage induced by the complex [LIrcIrh], exhibiting ablaze evidence for the destruction of TNBC cells through ferroptosis.

Fabrication of highly biocompatible SiO2@Au-BSA nanoconjugates: Towards a promising thermal therapy route

SiO2@Au nanoshells have gained relevance in recent years, especially in biomedical areas, acting as thermal therapy agents due to their high capacity to absorb light and transform it into heat that increases the temperature of the medium. Therefore, it is important to develop methodological strategies to obtain stable, highly specific and biocompatible nanoparticles. In this work, the synthesis of core-shell structures based on SiO2@Au is reported, where the growth a thin shell ⁓ 46 nm on silica platform was possible. Subsequently, optimal conditions were developed for the binding of a bovine serum albumin (BSA) protein using a thiolated linker such as mercaptoethanol. Likewise, the photothermal conversion capacity was investigated using thermal lens spectroscopy. Thermal diffusivity values were reported for the first time during the conjugation process of gold nanoshells, where an increase of 37.5 % was recorded as the conjugation was completed. Finally, the cytotoxic potential of the developed nanoconjugates was evaluated through their hemolytic rate in human red blood cells. The findings suggest high hemocompatibility of the SiO2@Au-BSA complex because they did not cause significant oxidative stress and are classified as nonhemolytic. Therefore, in this work we propose a synthesis route for a thermal agent based on SiO2@Au and bovine serum albumin, highly biocompatible and with high photothermal conversion. The results of this work aim to clarify the safety of using gold nanoshells as a thermal therapy agent.

Structural Aspects, Binding Interactions, Biological Activity of Co(II)‐ and Ni(II)‐N′‐(2‐fluorobenzoyl)benzo[d]thiazole‐2‐carbohydrazide Chelatess

ABSTRACTN′‐(2‐Fluorobenzoyl)benzo[d]thiazole‐2‐carbohydrazide (OFBBTCH, HL) and its chelates with Co(II) and Ni(II) have been synthesized and characterized by elemental analysis, liquid chromatography‐mass spectrometry (LC–MS), Fourier transform infrared spectroscopy (FT‐IR), ultra‐violet visible (UV–vis), nuclear magnetic resonance (NMR) spectroscopy, thermogravimetric analysis (TGA), and powder X‐ray diffraction. The conductance measurements reveal that the chelates are non‐electrolytic, and the spectral analysis indicates octahedral geometry of the chelates. The kinetic and thermodynamic parameters were obtained by Coats–Redfern relations, which shows positive Gibbs's free energy and negative entropy for both chelates. The equilibrium studies carried out by pH‐metry revealed the dissociation constant (pKa) of OFBBTCH as 8.13 and the formation of 1:1 and 1:2 Co(II)‐L and Ni(II)‐L complexes in solution. The CT‐DNA binding studies carried out by electron absorption, fluorescence quenching, steady state emissions and viscosity studies revealed hyperchromism and groove binding for HL and chelates. The Kb values calculated from electron absorption studies are 2.4 × 106, 4 × 106, and 9 × 106 M−1, from the fluorescence quenching studies Ksv values are 0.1722, 0.278, and 0.748 M−1, and Kapp values are 5.9 × 104, 1.3 × 105, and 2.9 × 105 M−1 for HL, Co(II)‐OFBBTCH and Ni(II)‐OFBBTCH, respectively. Bovine serum albumin (BSA) and human serum albumin (HSA) binding interactions were carried out by electron absorption and fluorescence quenching studies. The light switching properties of the chelates, the hydrolytic and oxidative cleavage of CT‐DNA, and the antioxidant properties were evaluated. Anti‐microbial studies carried out by pour plate method showed high activity for Ni(II)‐OFBBTCH chelate. Cytotoxicity of the compounds was performed for HeLa and MCF cell lines by MTT assay. Molecular docking studies revealed the docking of HL and Co(II)‐HL at the minor groove, and Ni(II)‐HL was docked at the major groove with hydrogen bonding.

A cobalt coordination complex binds on a unique binding site between domain-I and domain-III of serum albumin

Serum albumin binding influences physiological effects and pharmacokinetics of drugs. Major binding sites in serum albumin are sudlow sites I and II, located on domains IIA and IIIA, respectively. However, groove between domain I and III as a binding site is not well studied. In this work, we studied the binding of a cobalt coordination complex (DCoP) with bovine serum albumin (BSA) using multi-spectroscopic methods and molecular docking. DCoP strongly interacts with BSA with association constant of ∼7 × 105M−1. The binding was found to significantly alter protein's conformation and unfolding pathway. Results of this study shows that DCoP binds at the groove formed between domains III and I. We conclude that the groove is a rare binding site for large molecules and coordination complexes. The knowledge of unique binding site of serum albumin enlightens the comprehensive role of protein as a carrier biomacromolecule.

Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model

The approval of splice-switching oligonucleotides with phosphorodiamidate morpholino oligomers (PMOs) for treating Duchenne muscular dystrophy (DMD) has advanced the field of oligonucleotide therapy. Despite this progress, PMOs encounter challenges such as poor tissue uptake, particularly in the heart, diaphragm, and central nervous system (CNS), thereby affecting patient’s prognosis and quality of life. To address these limitations, we have developed a PMOs-based heteroduplex oligonucleotide (HDO) technology. This innovation involves a lipid-ligand-conjugated complementary strand hybridized with PMOs, significantly enhancing delivery to key tissues in mdx mice, normalizing motor functions, muscle pathology, and serum creatine kinase by restoring internal deleted dystrophin expression. Additionally, PMOs-based HDOs normalized cardiac and CNS abnormalities without adverse effects. Our technology increases serum albumin binding to PMOs and improves blood retention and cellular uptake. Here we show that PMOs-based HDOs address the limitations in oligonucleotide therapy for DMD and offer a promising approach for diseases amenable to exon-skipping therapy.

Technetium-99m radiolabeling of graphene quantum dots (GQDs) as a new probe for glioblastoma tumor imaging

Purpose Cancer diagnosis involves a multi-step process. Accurate identification of the tumor, staging and development of cancer cells is crucial for selecting optimal treatments to minimize disease recurrence. Quantum dots (QDs) represent an exciting class of fluorescent nanoprobes in molecular detection and targeted tumor imaging. Materials and methods In this study, graphene quantum dots (GQDs) were synthesized by pyrolysis of citric acid (CA) as a carbon precursor under high temperatures. The morphology of the obtained GQDs was first characterized using physical (TEM and DLS) and spectroscopic (fluorescence, FTIR and UV–Vis) methods. In the following,99mTc-labeled GQDs were prepared in the presence of SnCl2.2H2O as a reducing agent between 95 and 100 °C. The biodistribution and tumor targeting efficiency of radiolabeled GQDs as a novel agent for C6 glioma tumor scintigraphy in an animal model were evaluated. Furthermore, organ uptake, human serum albumin binding and tumor accumulation were measured. Results The TEM image of the prepared GQDs showed a relatively uniform size distribution in the range of diameter 6-9 nm and spherical shape. Radiolabeled GQDs showed a radiochemical yield of >97% (n = 3). Through incubation in human serum, almost 15% of 99mTc-labeled GQDs degraded after 6 h. The amount of uptake in xenograft models of glioma C6 rats was 1.10 ± 0.36% of injection dose per gram after 1 h. The kidneys, intestinal and glioma tumor sites were observed via scintigraphy imaging. Conclusion Our data suggest that 99mTc-labeled GQDs, as a new radiotracer, efficiently accumulate in the tumor site and could be included as a radiotracer for detecting glioma tumors.

An in vitro and machine learning framework for quantifying serum albumin binding of per- and polyfluoroalkyl substances

Abstract Per- and polyfluoroalkyl substances (PFAS) are a diverse class of anthropogenic chemicals; many are persistent, bioaccumulative, and mobile in the environment. Worldwide, PFAS bioaccumulation causes serious adverse health impacts, yet the physiochemical determinants of bioaccumulation and toxicity for most PFAS are not well understood, largely due to experimental data deficiencies. As most PFAS are proteinophilic, protein binding is a critical parameter for predicting PFAS bioaccumulation and toxicity. Among these proteins, human serum albumin (HSA) is the predominant blood transport protein for many PFAS. We previously demonstrated the utility of an in vitro differential scanning fluorimetry assay for determining relative HSA binding affinities for 24 PFAS. Here, we report HSA affinities for 65 structurally diverse PFAS from 20 chemical classes. We leverage these experimental data, and chemical/molecular descriptors of PFAS, to build 7 machine learning classifier algorithms and 9 regression algorithms, and evaluate their performance to identify the best predictive binding models. Evaluation of model accuracy revealed that the top performing classifier model, logistic regression, had an AUROC statistic of 0.936. The top performing regression model, support vector regression, had an R2 of 0.854. These top performing models were then used to predict HSA-PFAS binding for chemicals in the EPAPFASINV list of 430 PFAS. These developed in vitro and in silico methodologies represent a high-throughput framework for predicting protein-PFAS binding based on empirical data, and generate directly comparable binding data of potential use in predictive modeling of PFAS bioaccumulation and other toxicokinetic endpoints.

Integrated system for temperature-controlled fast protein liquid chromatography. IV. Continuous ‘one-column’ ‘low-salt’ hydrophobic interaction chromatography

Systematic development of a temperature-controlled isocratic process for one-column low-salt hydrophobic interaction chromatography (HIC) of proteins employing a travelling cooling zone reactor (TCZR) system, is described. Batch binding and confocal scanning microscopy were employed to define process conditions for temperature-reversible binding of bovine serum albumin (BSA) which were validated in pulse-response temperature switching HIC experiments, before transferring to TCZR-HIC. A thin-walled stainless-steel column mounted with a movable assembly of copper blocks and Peltier elements (travelling cooling zone, TCZ) was used for TCZR-HIC. In pulse-response TCZR-HIC, 12 TCZ movements along the column desorbed 86.3% of the applied BSA monomers in 95.3% purity depleted >6-fold in 2–4 mers and nearly 260-fold in higher molecular weight (HMW) species. For continuous TCZR-HIC, the TCZ was moved 49–58 times during uninterrupted loading of BSA feeds at 0.25, 0.5 or 1 mg·mL-1. Each TCZ movement generated a sharp symmetrical elution peak. In the best case, (condition 1: 0.25 mg·mL-1 BSA; >17 mg BSA applied per mL of bed) the height of TCZ elution peaks approached pseudo-steady midway through the loading phase with no rise in baseline UV280 signal between peaks. Peak composition remained constant averaging 94.4% monomer, 5.6% 2–4 mers and <0.05% HMW. Monomers were recovered in quantitative yield depleted >3.1 fold in 2–4 mers and 92-fold in HMW species cf. the feed (63.6% monomers, 21.8% 2–4 mers, 14.6% HMW). However, increasing the BSA concentration to 1 mg·mL-1 (condition 2) or employing a fouled HIC column with 0.5 mg·mL-1 BSA (condition 3) compromised monomer purification performance.

GSH-responsive and folate receptor-targeted pyridine bisfolate-encapsulated chitosan nanoparticles for enhanced intracellular drug delivery in MCF−7 cells

Folic acid receptor-targeted drug delivery system is a promising candidate for tumor-targeted delivery because its elevated expression specifically on tumor cells enables the selective delivery of cytotoxic cargo to cancerous tissue, thereby minimizing toxic side effects and increasing the therapeutic index. Pyridine bisfolate-chitosan (PyBFA@CS NPs) and folate-chitosan nanocomposite (FA@CS NPs) were synthesized with suitable particle size (256.0 ± 15.0 and 161.0 ± 5.0 nm), high stability (ζ = −27.0 ± 0.1 and −30.0 ± 0.2 mV), respectively, and satisfactory biocompatibility to target cells expressing folate receptors and try to answer the question: Is the metal center always important for activity? Since almost all pharmaceuticals work by binding to specific proteins or DNA, the in vitro binding of human serum albumin (HSA) to PyBFA@CS NPs and FA@CS NPs has been investigated and compared with PyBFA. Strong affinity to HSA is shown by quenching and binding constants in the range of 105 and 104 M−1, respectively with PyBFA@CS NPs showing the strongest. The compounds-HSA kinetic stability, affinity, and association constants were investigated using a stopped-flow method. The findings showed that all formulations bind by a static quenching mechanism that consists of two reversible steps: rapid second-order binding and a more slowly first-order isomerization reaction. The overall coordination affinity of HSA to PyBFA@CS NPs (6.6 × 106 M−1), PyBFA (4.4 × 106 M−1), and FA@CS NPs (1.3 × 106 M−1) was measured and The relative reactivity is roughly (PyBFA@CS NPs)/(PyBFA)/(FA@CS NPs) = 5/3/1. Additionally, in vitro cytotoxicity revealed that, consistent with the binding constants and coordination affinity, active-targeting formulations greatly inhibited FR-positive MCF-7 cells in compared to FRs-negative A549 cells in the following trend: PyBFA@CS NPs > PyBFA > FA@CS NPs. Furthermore, in vitro drug release of PyBFA@CS NPs was found to be stable in PBS at pH 7.4, however, the in pH 5.4 and in pH 5.4 containing 10 mM glutathione (GSH) (mimicking the tumor microenvironment) reached 43 % and 73 %, respectively indicating that the PyBFA@CS NPs system is sensitive to GSH. Folate-modified nanoparticles, PyBFA@CS NPs, are a promising therapeutic for MCF-7 therapy because they not only showed a greater affinity for HSA, but also showed higher cleavage efficiency toward the minor groove of pBR322 DNA via the hydrolytic way, as well as effective antibacterial activity that avoids the usage of extra antibiotics.‬‬‬‬‬‬‬‬‬‬‬‬ ‬‬‬‬‬‬‬‬‬‬‬‬‬‬

On surface binding of serum albumin by harmane: An in vitro spectroscopic and theoretical analysis

Harmane, a naturally occurring beta-carboline alkaloid found in plants and animals, has sparked interest due to its potential biological impacts, specifically its neuro-pharmacological properties and its link with neurodegenerative ailments. This work studies the interaction between the bovine serum albumin (BSA) and the Harmane via multi-spectroscopic and computational analyses. Spectroscopic titrations at different temperatures and concentrations of the salt showed that Harmane forms a stable ground-state complex revealed by a static quenching of the fluorescence spectra. Thermodynamic characteristics of the binding show that BSA and Harmane have a 1:1 binding stoichiometry. The negative change in the Gibbs free energy (ΔG) indicates that the interaction is spontaneous, whereas the positive values of the change in entropy (ΔS) and the change in enthalpy (ΔH) indicate that hydrophobic forces predominate in the binding. The protein surface hydrophobicity index confirms significant surface hydrophobicity. The study also demonstrates the impact of metal ions on protein structure. According to molecular docking studies, Harmane binds to BSA in site II, domain III, subdomain IIIA. Molecular Dynamic (MD) modeling was used to reconfirm the perturbation in the stability and structure of the protein due to Harmane binding at different time frames.

Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies.

Early assessment of antibody off-target binding is essential for mitigating developability risks such as fast clearance, reduced efficacy, toxicity, and immunogenicity. The baculovirus particle (BVP) binding assay has been widely utilized to evaluate polyreactivity of antibodies. As a complementary approach, computational prediction of polyreactivity is desirable for counter-screening antibodies from in silico discovery campaigns. However, there is a lack of such models. Herein, we present the development of an ensemble of three deep learning models based on two pan-protein foundational protein language models (ESM2 and ProtT5) and an antibody-specific protein language model (PLM) (Antiberty). These models were trained in a transfer learning network to predict the outcomes in the BVP assay and the bovine serum albumin binding assay, which was developed as a complement to the BVP assay. The training was conducted on a large dataset of antibody sequences augmented with experimental conditions, which were collected through a highly efficient application system. The resulting models demonstrated robust performance on canonical mAbs (monospecific with heavy and light chain), bispecific Abs, and single-domain Fc (VHH-Fc). PLMs outperformed a model built using molecular descriptors calculated from AlphaFold 2 predicted structures. Embeddings from the antibody-specific and foundational PLMs resulted in similar performance. To our knowledge, this represents the first application of PLMs to predict assay data on bispecifics and VHH-Fcs.

Bovine Serum Albumin Bends Over Backward to Interact with Aged Plastics: A Model for Understanding Protein Attachment to Plastic Debris.

Plastic pollution, a major environmental crisis, has a variety of consequences for various organisms within aquatic systems. Beyond the direct toxicity, plastic pollution has the potential to absorb biological toxins and invasive microbial species. To better understand the capability of environmental plastic debris to adsorb these species, we investigated the binding of the model protein bovine serum albumin (BSA) to polyethylene (PE) films at various stages of photodegradation. Circular dichroism and fluorescence studies revealed that BSA undergoes structural rearrangement to accommodate changes to the polymer's surface characteristics (i.e., crystallinity and oxidation state) that occur as the result of photodegradation. To understand how protein structure may inform docking of whole organisms, we studied biofilm formation of bacteriaShewanella oneidensison the photodegraded PE. Interestingly, biofilms preferentially formed on the photodegraded PE that correlated with the state of weathering that induced the most significant structural rearrangement of BSA. Taken together, our work suggests that there are optimal physical and chemical properties of photodegraded polymers that predict which plastic debris will carry biochemical or microbial hitchhikers.

#2931 Advancing personalized extracorporeal therapies for albumin bound toxins through serum albumin binding function

Abstract Background and Aims Liver failure poses a significant clinical challenge with compromised functionality of the liver and accumulation of toxic metabolites. The lack of bedside-compatible methods to evaluate treatment response during therapy underscores the urgent need for refined diagnostic tools. Albumin, the principal transport protein, reflecting the elevated toxin and metabolite levels in liver failure, assumes a critical role in assessing the severity of hepatic dysfunction. This research introduces a novel method centered on a dansylsarcosine-based kinetic modeling of serum albumin binding, aiming to improve therapeutic decision-making in hepatic failure. This biomarker is designed to offer critical insights into albumin's dynamic interactions, essential for assessing liver function and effectiveness of therapeutic interventions. The study aims to supplement existing diagnostic methods, providing a more comprehensive evaluation of irreversible damages of albumin in liver failure and guiding more effective treatment strategies. Method In this study, we employed a novel method for measuring binding affinity at varying levels of dansylsarcosine, aiming to describe the kinetic properties of the Sudlow II binding site. The binding behavior of albumin under various concentrations of dansylsarcosine was characterized using a modified Michaelis-Menten kinetic model. To enhance accuracy, a formula correction was employed for both intrinsic absorbance and the influence of dansylsarcosine. The method facilitates kinetic modeling, exploring the behavior of the binding site under diverse ligand concentrations. Emerging from this are two key players: Bmax and Kd. Bmax quantifies the maximum capacity of binding sites available for occupation by dansylsarcosine. Kd signifies the concentration of dansylsarcosine at which half of the Sudlow II binding sites are saturated. The method was applied to a patient database of patients with hepatic failure treated with OPAL or MARS liver support systems (albumin dialysis with albumin regeneration). The applied analysis focused on the correlation with existing clinical scores and the description of therapeutic effects. Results The new method correlates with established markers, scores and therapeutic effects. For Patient samples from the OPALESCE database, Bmax and Kd exhibited correlations with established albumin biomarkers. Subgroup analysis revealed associations with clinical scores such as GCS, SOFA, MELD, ACLF, CLIF-OF and ABiC emphasizing the clinical relevance of Bmax and Kd values. Therapeutic effects were assessed using the OPALESCE database, demonstrating the capability of Bmax and Kd to describe therapy outcomes. Significant differences between the start and end of the first treatment were detected for MARS with Bmax and OPAL with Kd. Bmax and Kd values proved to be valuable indicators for therapeutic effects, aligning with established parameters such as ABiC and the CLIF-OF Score. These findings underscore the potential clinical utility of Bmax and Kd as robust markers for assessing therapy outcomes in liver support interventions. Conclusion The results help to provide a comprehensive understanding of albumin binding dynamics in patients with hepatic failure, offering a valuable tool for therapeutic decisions. The impact of therapy can be described using Bmax and Kd, both of which correlate with established clinical scores within the patient population. Bmax unveils irreversible damages to the albumin molecule, showcasing its potential to identify scenarios where applied therapies fail to enhance albumin binding functions. This insight prompts the consideration of alternative therapeutic pathways, including the consideration of therapeutic plasma exchange when extracorporeal methods are insufficient, showcasing the biomarker's utility in guiding precision therapeutic decisions for improved outcomes in hepatic failure management. The significance of albumin function for uraemic toxins needs to be further investigated. Optimization of dialysis for patients with renal insufficiency appears possible.

DNA and bovine serum albumin protein (BSA) interaction of antitumor supramolecular nickel(II) complex: Inference for drug design

To explore the therapeutic potential of supramolecular nickel(II) Schiff base self-assemble complexes, the Schiff base ligand (N, N′-bis(salicylidene)-1,3-diamino-2-propanol) and its Ni(II) complex [Ni2(H2L)2(NCS)2(CH3OH)2](CH3OH)2 were synthesized. Characterization by X-ray crystallography (for the complex), FT-IR, UV–Vis spectroscopy, 1HNMR and elemental analysis (CHN) were performed. Single-crystal X-ray structure of the complex exhibited a distorted octahedral geometry in which each nickel(II) center, in the asymmetric unit, was six coordinated with three N atoms and three O atoms (from Schiff base ligand, methanol and NCS). In vitro Fish Sperm DNA (FS-DNA) and Bovine Serum Albumin (BSA) binding studies of the complex employed UV–Vis and fluorescence spectroscopy, cyclic voltammetry, viscosity measurement and molecular docking. The complex indicated a good binding propensity to BSA and was also bound to FS-DNA, preferably via intercalation. The outputs of the molecular docking study confirmed the experimental results. The complex was found to exert high anticancer activity against the gastric and prostate cancerous cells with putative selective anticancer properties. The death-induced mechanism underlying the complex is mainly related to the intercalator interactions, which may result in apoptosis-programmed cell death.

Organoruthenium metallocycle induced mutation in gld-1 tumor suppression gene in JK1466 strain and appreciable lifespan expansion

Four Ru(II) complexes (A2-A5) were synthesized from the reaction of coumarin Schiff base ligands (7da2-tsc, 7da3-mtsc, 7da4-etsc and 7da5-ptsc) with [RuHCl(CO)(PPh3)3]. The compounds were characterized by FT-IR, UV–Vis, 1H, 13C and 31P NMR, mass spectrometry and crystallographic analysis. Calf Thymus DNA (CT-DNA) binding studies revealed the intercalative mode of binding of the complexes with DNA. The results of Bovine serum albumin (BSA) binding studies established the interaction between BSA followed static quenching mechanism. The cytotoxic effects of the complexes and the ligands were evaluated against breast (MCF-7 and MDA-MB-231) and lung carcinoma cell lines (A549 and NCI-H460) using MTT assay. Complex A4 demonstrated potent cytotoxic effects on both breast and lung cancer cells. Furthermore, morphological observations and FACS analysis showed the decrease in cell density by complex A4 by induced morphological changes and apoptotic body formation and cell death in both breast and lung cancer cells. Moreover, the invertebrate model Caenorhabditis elegans was employed to assess the in vivo anticancer activity of compound A4. The findings indicated that the treatment with A4 reduced tumor development and significantly extended organismal lifespan by 64 % in the tumoral strain JK1466 without adversely affecting essential physiological functions of the worm. Additionally, A4 demonstrated an upregulation of two crucial antioxidant defense genes. Overall, these results suggested that the compound A4 can be a potential candidate with novel chemotherapeutic applications.

Half-life extension of single-domain antibody-drug conjugates by albumin binding moiety enhances antitumor efficacy.

Single-domain antibody-drug conjugates (sdADCs) have been proven to have deeper solid tumor penetration and intratumor accumulation capabilities due to their smaller size compared with traditional IgG format ADCs. However, one of the key challenges for improving clinical outcomes of sdADCs is their abbreviated in vivo half-life. In this study, we innovatively fused an antihuman serum albumin (αHSA) nanobody to a sdADCs targeting oncofetal antigen 5T4, conferring serum albumin binding to enhance the pharmacokinetic profiles of sdADCs. The fusion protein was conjugated with monomethyl auristatin E (MMAE) at s224c site mutation. The conjugate exhibited potent cytotoxicity against various tumor cells. Compared with the nonalbumin-binding counterparts, the conjugate exhibited a 10-fold extended half-life in wild-type mice and fivefold prolonged serum half-life in BxPC-3 xenograft tumor models as well as enhanced tumor accumulation and retention in mice. Consequently, n501-αHSA-MMAE showed potent antitumor effects, which were comparable to n501-MMAE in pancreatic cancer BxPC-3 xenograft tumor models; however, in human ovarian teratoma PA-1 xenograft tumor models, n501-αHSA-MMAE significantly improved antitumor efficacy. Moreover, the conjugate showed mitigated hepatotoxicity. In summary, our results suggested that fusion to albumin-binding moiety as a viable strategy can enhance the therapeutic potential of sdADCs through optimized pharmacokinetics.

Investigating the Serum Albumin Binding Behavior of Naphthalimide Based Fluorophore Conjugates: Spectroscopic and Molecular Docking Approach.

In the present study, naphthalimide-pyrazole-benzothiazole based fluorescent analogs were synthesized by substituting different primary and secondary amines on the naphthalimide nucleus and were evaluated for their sensitivity and selectivity towards serum albumin. Among various synthesized analogues compound 25 showed the most significant change with serum albumin and was further studied for selective detection and mode of interaction with serum albumin. Here, we compared the binding interaction of fluorescent probe 25 for variation/detection of two 76 % structurally resembling proteins HSA and BSA, by spectroscopic experiments. The compound shows more selectivity for HSA and BSA with a higher binding constant and evident visible change in the emission spectra of two serum albumins among different bioanalytes. The mode of interaction of 25 with human serum albumin and bovine serum albumin was investigated by FT-IR, circular dichroism, and DLS techniques to find out the change in the microenvironment and variation in the structure of serum albumin proteins. Higher binding affinity and specific selectivity of 25 with a limit of detection of 0.69 μM and 1.4 μM towards HSA and BSA compared to other bioanalytes make it a significant fluorescent probe for quantitatively detecting serum albumins at the very early stage of many fatal diseases.

Design, Synthesis, Biological Evaluation and in Silico Studies of Curcumin Pyrrole Conjugates.

Curcumin conjugated heterocyclic compounds are potent candidates with drug likeness against various bacterial pathogens. A set of curcumin-based pyrrole conjugates (CPs) were synthesized and characterized by FT-IR, 1H and 13C NMR and HR-MS techniques. The results of free radical scavenging activity of the synthesized CPs, evaluated by FRAP and CUPRAC assays, showed the potency of these compounds as effective antioxidants. CP3 exhibits the highest antioxidant activity amongst the CPs. The bactericidal efficacy of CPs was screened against ESKAP bacterial pathogens, and CPs were found to possess better antibacterial property than curcumin, specifically against staphylococcus aureus bacteria. In addition, serum albumin (BSA and HSA) binding interaction of these CPs were determined by UV-visible and fluorescence spectrophotometric techniques. In-silico molecular docking study was performed to determine the binding patterns of molecular targets against Staphylococcus aureus tyrosyl tRNA synthetase, and serum albumin proteins. The structure-activity relationship showed that the presence of multiple phenolic hydroxyl groups, and electron withdrawing groups on the structure of CP molecule, enhances its antioxidant and antibacterial activity, respectively.

Bisphenol a modification and how its structure influences human serum albumin binding force

Bisphenol A (BPA) is an environmental hormone with substantial physiological toxicity to the human body. Three electron-withdrawing derivatives of BPA are synthesized in this study to reduce its toxicity. The interaction mechanism between BPA and its three derivatives with human serum albumin (HSA) is investigated using molecular docking, electrochemistry, circular dichroism spectrum analysis, and fluorescence spectroscopy. Temperature-dependent tests and time-resolved fluorescence spectra reveal that all four compounds dynamically quench the internal fluorescence of HSA. Based on molecular docking and site competition outcomes, four compounds are primarily bound to site I's active pocket. Thermodynamic parameters indicate that the compounds’ interaction with HSA is spontaneous, and introducing weak electron-withdrawing groups changes the action force. Circular dichroism and synchronous fluorescence measurements suggest four compounds impact HSA's structure. The substituents' electron attraction capacity determines their impact. Electrochemical studies examine the effect of electron-absorbing groups on the BPA and HSA binding capacity. Pharmacokinetics showed that nitro-substituted BPA may be a potential superior substitute for BPA. These results indicate crucial practical value, providing theoretical support for future research.

Quantitative cross-species comparison of serum albumin binding of per- and polyfluoroalkyl substances from five structural classes.

Per- and polyfluoroalkyl substances (PFAS) are a class of over 8000 chemicals, many of which are persistent, bioaccumulative, and toxic to humans, livestock, and wildlife. Serum protein binding affinity is instrumental in understanding PFAS toxicity, yet experimental binding data is limited to only a few PFAS congeners. Previously, we demonstrated the usefulness of a high-throughput, in vitro differential scanning fluorimetry assay for determination of relative binding affinities of human serum albumin for 24 PFAS congeners from 6 chemical classes. In the current study, we used this assay to comparatively examine differences in human, bovine, porcine, and rat serum albumin binding of 8 structurally informative PFAS congeners from 5 chemical classes. With the exception of the fluorotelomer alcohol 1H, 1H, 2H, 2H-perfluorooctanol (6:2 FTOH), each PFAS congener bound by human serum albumin was also bound by bovine, porcine, and rat serum albumin. The critical role of the charged functional headgroup in albumin binding was supported by the inability of albumin of each species tested to bind 6:2 FTOH. Significant interspecies differences in serum albumin binding affinities were identified for each of the bound PFAS congeners. Relative to human albumin, perfluoroalkyl carboxylic and sulfonic acids were bound with greater affinity by porcine and rat serum albumin, and the perfluoroalkyl ether acid congener bound with lower affinity to porcine and bovine serum albumin. These comparative affinity data for PFAS binding by serum albumin from human, experimental model, and livestock species reduce critical interspecies uncertainty and improve accuracy of predictive bioaccumulation and toxicity assessments for PFAS.